1. Analyst View
2. Research Methodology
3. Biologics Market Outlook to 2015
3.1 Market Size
3.2 Market Segmentation
4. Market Trends & Drivers
4.1 Rising Business Alliances Aiding in Biosimilar Development
4.2 Governments Realizing the Potential in Biosimilars, Encouraging Industry Growth
4.3 Biosimilar Players in US to Prefer BLA over Abbreviated Pathway
5. Biosimilars Market Outlook to 2015
6. Erythropoietin Market Outlook to 2015
6.1 Scientific Insight
6.2 Market Analysis
6.3 Recent Activities
7. Competitive Landscape
7.1 Hospira
7.2 Sandoz GmbH
7.3 Dr. Reddy's Labs (DRL)
7.4 3 SBio Inc
7.5 Teva